Granulated colloidal silicon dioxide-based self-microemulsifying tablets, as a versatile approach in enhancement of solubility and therapeutic potential of anti-diabetic agent: formulation design and in vitro/in vivo evaluation

References

• Thomsen MK. Mechanisms of action of repaglinide at a cellular level. Diabetes Metab 1999;7:3–11.
   Google Scholar
• Hatorp V. Clinical pharmacokinetics and pharmacodynamics of repaglinide. Clin Pharmacokinet 2002;41:471–83.
   PubMed Web of Science ®Google Scholar
• Mandic Z, Gabelica V. Ionization, lipophilicity and solubility properties of repaglinide. J Pharm Biomed Anal 2006;41:866–71.
   PubMed Web of Science ®Google Scholar
• Hatorp V, Oliver S, Su CA. Bioavailability of repaglinide, a novel anti-diabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers. Int J Clin Pharmacol Ther 1998;36:636–41.
   PubMed Web of Science ®Google Scholar
• Gadadare R, Mandpe L, Pokharkar V. Ultra rapidly dissolving repaglinide nanosized crystals prepared via bottom up and top-down approach: influence of food on pharmacokinetics behavior. AAPS PharmSciTech 2015;36:787–99.
   Web of Science ®Google Scholar
• Charman WN. Lipids, lipophilic drugs, and oral drug delivery – some emerging concepts. J Pharm Sci 2000;9:67–978.
   Google Scholar
• Wasan KM. Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems. Drug Dev Ind Pharm 2001;27:267–76.
   PubMed Web of Science ®Google Scholar
• Shah NH, Carvajal MT, Patel CI, et al. Selfemulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994;106:15–23.
   Web of Science ®Google Scholar
• Farah N, Laforet JP, Denis J. Self-micro emulsifying drug delivery systems (SMEDDS) for improving dissolution and bioavailability of poorly soluble active ingredients. B T Gattefossé 1994;87:41–7.
   Google Scholar
• Craig DQM, Barket SA, Banning D, Booth SW. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequencies dielectric spectroscopy. Int J Pharm 1995;114:103–10.
   Web of Science ®Google Scholar
• Qi X, Qin J, Ma N, et al. Solid self-microemulsifying dispersible tablets of celastrol: formulation development, characterization and bioavailability evaluation. Int J Pharm 2014;472:40–7.
   PubMed Web of Science ®Google Scholar
• Sohn Y, Lee SY, Lee GH, et al. Development of self-microemulsifying bilayer tablets for pH-independent fast release of Candesartan cilexetil. Pharmazie 2012;67:917–24.
   PubMed Web of Science ®Google Scholar
• Cirri M, Roghi A, Valleri M, Mura P. Development and characterization of fast-dissolving tablet formulations of glyburide based on solid self-microemulsifying systems. Eur J Pharm Biopharm 2016;104:19–29.
   PubMed Web of Science ®Google Scholar
• Thongrangsalit S, Phaechamud T, Lipipun V, Ritthidej GC. Bromocriptine tablet of self-microemulsifying system adsorbed onto porous carrier to stimulate lipoproteins secretion for brain cellular uptake. Colloids Surf B Biointerfaces 2015;131:162–9.
   PubMed Web of Science ®Google Scholar
• Čerpnjak K, Pobirk AZ, Vrečer F, Gašperlin M. Tablets and minitablets prepared from spray-dried SMEDDS containing naproxen. Int J Pharm 2015;495:336–46.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang R, Wu J, Shen Q. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery. Int J Pharm 2012;427:337–44.
   PubMed Web of Science ®Google Scholar
• Iosio T, Voinovich D, Perissutti B, et al. Oral bioavailability of silymarin phytocomplex formulated as self-emulsifying pellets. Phytomedicine 2011;18:505–12.
   PubMed Web of Science ®Google Scholar
• Bachhav YG, Patravale VB. SMEDDS of glyburide: formulation, in vitro evaluation, and stability studies. AAPS PharmSciTech 2009;10:482–7.
   PubMed Web of Science ®Google Scholar
• Zhang J, Peng Q, Shi S, et al. Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin–phospholipid complex. Int J Nanomedicine 2011;6:3405–14.
   PubMed Web of Science ®Google Scholar
• Lei B, Zha W, Wang Y, et al. Development of a novel self micro-emulsifying drug delivery system (SMEDDS) for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunction. Mol Pharm 2010;7:844–53.
   PubMed Web of Science ®Google Scholar
• Khoo SM, Humberstone AJ, Porter CJ, et al. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm 1998;167:155–64.
   Web of Science ®Google Scholar
• Patel AR, Vavia PR. Preparation and in vivo evaluation of SMEDDS (Self Microemulsifying Drug Delivery System) containing fenofibrate. AAPS J 2007;9:344–52.
   PubMed Web of Science ®Google Scholar
• Borhade V, Nair H, Hegde D. Design and evaluation of Self-Microemulsifying Drug Delivery System (SMEDDS) of tacrolimus. AAPS PharmSciTech 2007;9:13–21.
   Web of Science ®Google Scholar
• Singh AK, Chaurasiya A, Singh M, et al. Exemestane loaded Self-Microemulsifying Drug Delivery System (SMEDDS): development and optimization. AAPS PharmSciTech 2008;2:629–34.
   Google Scholar
• Thakkar H, Nangesh J, Parmar M, Patel D. Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system. J Pharm Bioallied Sci 2011;3:442–8.
   PubMedGoogle Scholar
• Mandawgade SD, Sharma S, Pathak S, Patravale VB. Development of SMEDDS using natural lipophile: application to beta-Artemether delivery. Int J Pharm 2008;362:179–83.
   PubMed Web of Science ®Google Scholar
• Jaiswal P, Aggarwal G, Harikumar SL, Singh K. Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan. Int J Pharm Investig 2014;4:195–206.
   PubMedGoogle Scholar
• Yang R, huang X, Dou J, et al. Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation. Int J Nanomedicine 2013;8:2917–26.
   PubMed Web of Science ®Google Scholar
• Prajapati ST, Joshi HA, Patel CN. Preparation and characterization of self-microemulsifying drug delivery system of olmesartan medoxomil for bioavailability improvement. J Pharm 2014;10:1–9.
   Google Scholar
• Maghraby GME, Osman MA, Elrahmanc HEA, Elsisi AE. Self emulsifying liquisolid tablets for enhanced oral bioavailability of repaglinide: in vitro and in vivo evaluation. JAPS 2014;4:12–21.
   Google Scholar
• Ghosh S, Bhattacharya S, Rashid K, Sil PC. Curcumin protects rat liver from streptozotocin-induced diabetic pathophysiology by counteracting reactive oxygen species and inhibiting the activation of p53 and MAPKs mediated stress response pathways. Toxicol Rep 2014;2:365–76.
   Google Scholar
• Ganda OP, Rossini AA, Like AA. Studies on streptozotocin diabetes. Diabetes 1976;25:595–603.
   PubMed Web of Science ®Google Scholar
• Bera K, Khanam J, Mohanraj KP, Mazumder B. Design and evaluation of mucoadhesive beads of glipizide as a controlled release drug delivery system. J Microencapsul 2014;31:220–9.
   PubMed Web of Science ®Google Scholar
• Quan DQ, Xu GX, Wu XG. Studies on preparation and absolute bioavailability of a self emulsifying system containing puerarin. Chem Pharm Bull 2007;55:800–3.
   PubMed Web of Science ®Google Scholar
• Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev 1997;25:47–58.
   Web of Science ®Google Scholar
• Rosano HL, Lan T, Welss A, et al. Unstable microemulsions. J Php Chem 1981;85:468–73.
   Web of Science ®Google Scholar
• Constanitinides PP, Scalart JP, Lancaster C, et al. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsion incorporating medium-chain glycerides. Pharm Res 1994;11:1385–90.
   PubMed Web of Science ®Google Scholar
• Elnaggar YSR, Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm 2009;380:133–41.
   PubMed Web of Science ®Google Scholar
• Kinnari P, Mäkilä E, Heikkilä T, et al. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int J Pharm 2011;414:148–56.
   PubMed Web of Science ®Google Scholar